These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 16797705

  • 21. Deletion of c-myb exon 9 induced by insertion of repeats.
    Shinagawa T, Ishiguro N, Horiuchi M, Matsui T, Okada K, Shinagawa M.
    Oncogene; 1997 Jun 12; 14(23):2775-83. PubMed ID: 9190893
    [Abstract] [Full Text] [Related]

  • 22. Epigenetic regulation of PRAME gene in chronic myeloid leukemia.
    Roman-Gomez J, Jimenez-Velasco A, Agirre X, Castillejo JA, Navarro G, Jose-Eneriz ES, Garate L, Cordeu L, Cervantes F, Prosper F, Heiniger A, Torres A.
    Leuk Res; 2007 Nov 12; 31(11):1521-8. PubMed ID: 17382387
    [Abstract] [Full Text] [Related]

  • 23. Molecular profiling of chronic myeloid leukemia in eastern India.
    Mondal BC, Bandyopadhyay A, Majumdar S, Mukhopadhyay A, Chandra S, Chaudhuri U, Chakrabarti P, Bhattacharyya S, Dasgupta UB.
    Am J Hematol; 2006 Nov 12; 81(11):845-9. PubMed ID: 16888785
    [Abstract] [Full Text] [Related]

  • 24. [GPI-PLD gene exon14 polymorphisms of leucocyte in peripheral blood from healthy persons and leukemia patients].
    Yang ZY, Huang H, Tang JH, Yu H, Wang YD, Xiang XY.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Feb 12; 31(1):28-31. PubMed ID: 16562670
    [Abstract] [Full Text] [Related]

  • 25. Chronic myeloid leukemia blast crisis arises from progenitors.
    Michor F.
    Stem Cells; 2007 May 12; 25(5):1114-8. PubMed ID: 17218393
    [Abstract] [Full Text] [Related]

  • 26. Aberrant methylation of the death-associated protein kinase 1 (DAPK1) CpG island in chronic myeloid leukemia.
    Qian J, Wang YL, Lin J, Yao DM, Xu WR, Wu CY.
    Eur J Haematol; 2009 Feb 12; 82(2):119-23. PubMed ID: 19018866
    [Abstract] [Full Text] [Related]

  • 27. Comprehensive analysis of BCR-ABL transcript types in Korean CML patients using a newly developed multiplex RT-PCR.
    Goh HG, Hwang JY, Kim SH, Lee YH, Kim YL, Kim DW.
    Transl Res; 2006 Nov 12; 148(5):249-56. PubMed ID: 17145570
    [Abstract] [Full Text] [Related]

  • 28. Cryptic and partial deletions of PRDM16 and RUNX1 without t(1;21)(p36;q22) and/or RUNX1-PRDM16 fusion in a case of progressive chronic myeloid leukemia: a complex chromosomal rearrangement of underestimated frequency in disease progression?
    Deluche L, Joha S, Corm S, Daudignon A, Geffroy S, Quief S, Villenet C, Kerckaert JP, Laï JL, Preudhomme C, Roche-Lestienne C.
    Genes Chromosomes Cancer; 2008 Dec 12; 47(12):1110-7. PubMed ID: 18767145
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Study of calcitonin gene methylation in chronic myeloid leukemia by using Hpa II-PCR].
    Tan B, Cao P, Qi Z.
    Hunan Yi Ke Da Xue Xue Bao; 1999 Dec 12; 24(4):371-3. PubMed ID: 12080652
    [Abstract] [Full Text] [Related]

  • 32. Decreased expression level of SH2 domain-containing protein tyrosine phosphatase-1 (Shp1) is associated with progression of chronic myeloid leukaemia.
    Amin HM, Hoshino K, Yang H, Lin Q, Lai R, Garcia-Manero G.
    J Pathol; 2007 Aug 12; 212(4):402-10. PubMed ID: 17503411
    [Abstract] [Full Text] [Related]

  • 33. [Monitoring of minimal residual disease in patients with chronic myeloleukemia: clinical value of real-time polymerase chain reaction].
    Chelysheva EIu, Turkina AG, Misiurin AV, Aksenova EV, Domracheva EV, Zakharova AV, Khoroshko ND.
    Ter Arkh; 2007 Aug 12; 79(4):49-53. PubMed ID: 17564019
    [Abstract] [Full Text] [Related]

  • 34. [Quantitative study on C/EBP zeta gene transcripts in patients with chronic myeloid leukemia using real-time quantitative PCR].
    Qian J, Chen ZX, Lin J, Hu SY, Cen JN, Wang W.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Dec 12; 22(6):628-31. PubMed ID: 16331558
    [Abstract] [Full Text] [Related]

  • 35. Absence of somatic changes in p21 gene in non-Hodgkin's lymphoma and chronic myelogenous leukemia.
    Gong JZ, Zhou H, Hu Z, Schulman P, Vinceguerra V, Broome JD, Koduru P.
    Hematol Pathol; 1995 Dec 12; 9(3-4):171-7. PubMed ID: 8655461
    [Abstract] [Full Text] [Related]

  • 36. Imatinib mesylate resistance in a chronic myeloid leukemia patient with a novel e8a2 BCR-ABL transcript variant.
    Qin YZ, Jiang B, Jiang Q, Zhang Y, Jiang H, Li JL, Zhu HH, Li LD, Liu YR, Chen SS, Huang XJ.
    Acta Haematol; 2008 Dec 12; 120(3):146-9. PubMed ID: 19039205
    [Abstract] [Full Text] [Related]

  • 37. Technology evaluation: leukemia therapy, University of Pennsylvania.
    Orr RM.
    Curr Opin Mol Ther; 1999 Jun 12; 1(3):399-403. PubMed ID: 11713805
    [Abstract] [Full Text] [Related]

  • 38. Stem cell regulation and the development of blast crisis in chronic myeloid leukemia: Implications for the outcome of Imatinib treatment and discontinuation.
    Wodarz D.
    Med Hypotheses; 2008 Jun 12; 70(1):128-36. PubMed ID: 17566666
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Alternative BCR/ABL splice variants in Philadelphia chromosome-positive leukemias result in novel tumor-specific fusion proteins that may represent potential targets for immunotherapy approaches.
    Volpe G, Cignetti A, Panuzzo C, Kuka M, Vitaggio K, Brancaccio M, Perrone G, Rinaldi M, Prato G, Fava M, Geuna M, Pautasso M, Casnici C, Signori E, Tonon G, Tarone G, Marelli O, Fazio VM, Saglio G.
    Cancer Res; 2007 Jun 01; 67(11):5300-7. PubMed ID: 17545610
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.